11:05 〜 11:30

[2AW20-6] Integrated Patient-Derived Models of Lethal Prostate Cancer

【E】

〇Mitchell Lawrence^1,2,6、Obinata Daisuke^1,6、Shahneen Sandhu^2,6、Luke Selth^3,6、Stephen Wong^2,6、Laura Porter¹、Natalie Lister¹、Hong Wang¹、Birunthi Niranjan¹、Arun Azad¹、David Pook¹、Carmel Pezaro¹、David Goode²、Richard Rebello¹、Melissa Papargiris¹、Jenna van Gramburg¹、Heather Thorne^2,4、Catherine Mitchell²、John Pedersen¹、Wayne Tilley³、Richard Pearson²、Ross Hannan^2,5、Mark Frydenberg¹、Luc Furic^1,2、Renea Taylor^1,2,6、Gail Risbridger^1,2,6 (1.Monash University、2.Peter MacCallum Cancer Centre、3.University of Adelaide、4.kConfab、5.Australian National University、6.Authors contributed equally)

Prostate cancer、Metastasis、Patient-derived xenograft、Androgen receptor、Therapeutic resistance